• Corpus ID: 23552804

Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).

@article{Corbett1982ToxicityAA,
  title={Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).},
  author={Thomas H. Corbett and Wilbur R. Leopold and Donald J. Dykes and Billy J. Roberts and Daniel P. Griswold and Frank M. Schabel},
  journal={Cancer research},
  year={1982},
  volume={42 5},
  pages={
          1707-15
        }
}
A new triazine folate antagonist, 3-chloro-4-((4-(2-chloro-4-[4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl]phenyl)butyl)) benzenesulfonyl fluoride compounded with ethanesulfonic acid (1:1) (NSC 127755), was highly active against four transplantable colon adenocarcinomas (36, 38, 10/A, 12/A) and the Dunning murine ovarian tumor M5076. Treatment schedule studies indicated that a prolonged time of exposure provided optimum antitumor activity for the compound. The combination of NSC 127755 plus 4… 

Tables from this paper

Preclinical antitumor activity of CI-994
TLDR
CI-994 had the same spectrum of activity in vivo as dinaline and behaved similarly in schedule comparison/toxicity trials, and prolonged administration with lower drug doses was more effective than short-term therapy at higher individual doses.
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate
TLDR
Assure® had no selective cytotoxicity for solid tumors in the disk-assay, and was devoid of antitumor activity, while the analog XK469 is in clinical development.
Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
TLDR
A series of 5-[(aminoalkyl)amino]-substituted anthra[1,9-cd] pyrazol-6(2H)ones (anthrapyrazoles) were synthesized and suggest that they are similar to doxorubicin in both degree and spectrum of activity.
Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169
TLDR
There was no absolute tissue of origin correlation with antitumor efficacy, although colon tumors were most responsive and mammary tumors least responsive, and the cause of the “hit and miss” efficacy has not been determined.
Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice
TLDR
The anticancer activity of RP 60475 against a variety of transplantable tumors of mice, and also its cross-resistance profile in leukemias are reported, which is found to be highly active and could induce 5/5 complete regressions of advanced stage tumor.
1,3,5-Triazine Analogs: A Potent Anticancer Scaffold
TLDR
Various 1,3,5-triazine analogs have shown potent activities and may be regarded as clinical candidates for future anticancer formulations and this review may be helpful to those researchers seeking required information with regard to the drug design and medicinal properties of 1-3, 5- triazine derivatives for selected targets.
Synthesis and Antimalarial-Activity Evaluation of TetraoxaneTriazine Hybrids and Spiro[piperidine-4,3′-tetraoxanes]
TLDR
A series of tetraoxanetriazine hybrids and spiro[piperidine-4,3′-tetraoxanes] exhibited moderate to good antimalarial activities, and two compounds have shown goodAntimalarial activity against both the strains with high selectivity index and no cytotoxicity towards mammalian kidney cell line.
Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
  • Mudasir Maqbool, Apra Manral, B. Jayaram
  • Chemistry, Biology
    Bioorganic & medicinal chemistry
  • 2016
...
...

References

SHOWING 1-10 OF 55 REFERENCES
Combination chemotherapy in sequence for the treatment of L1210 leukemia.
TLDR
Observations indicate that a variety of dosages of oncolytic drugs can be used to produce equivalent therapeutic response and that the order of administration may determine the overall effectiveness of sequential multiple-drug therapy.
The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.
TLDR
Results obtained with L1210 cells in vivo suggest that the combination of ara-C and methotrexate is capable of killing cells by a mechanism not related simply to DNA synthesis inhibition.
Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
TLDR
Enhanced Ara-C accumulation after administration of MTX was also observed in human acute myelogenous leukemia cells, and may be the consequence of greater inhibition of DNA polymerase by increased Ara- C triphosphate in the presence of the decreasing natural substrate of this enzyme, deoxycytidine triph phosphate.
Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas
TLDR
The results of surgery‐chemotherapy adjuvant treatment of metastatic colon tumors established that if an agent or a combination was highly active against moderately advanced tumor masses, this treatment was also highly active after surgery against residual metastatic disease.
Estrogen receptor characterization in a transplantable mouse mammary tumor.
TLDR
It is demonstrated that this tumor line contains relatively large quantities of estrogen receptors that are similar to those found in normal tissue, which makes it an ideal model system for the study of growth control by estrogens in neoplastic tissue.
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy.
TLDR
A mammary adenocarcinoma (16/C) was selected as a model from greater than 50 mammary tumors studied because it was highly metastatic and because it responded to most of the agents reported to be active against breast cancer in women.
Antitumor activity of interferon against murine osteogenic sarcoma cells in vitro.
TLDR
Inhibition of cell growth was significantly greater for OGS cells than for normal mouse embryo fibroblasts and the antitumor activity of the interferon preparation could be reversed by anti-interferon antibody.
Design of active-site-directed irreversible enzyme inhibitors : the organic chemistry of the enzymic active-site
TLDR
Reading a book as this design of active site directed irreversible enzyme inhibitors the organic chemistry of the enzymic active site and other references can enrich your life quality.
...
...